Close Menu
The Financial News 247The Financial News 247
  • Home
  • News
  • Business
  • Finance
  • Companies
  • Investing
  • Markets
  • Lifestyle
  • Tech
  • More
    • Opinion
    • Climate
    • Web Stories
    • Spotlight
    • Press Release
What's On

Hunter Biden’s $LAPTOP meme coin rockets from $3 to $300 — then crashes within minutes

September 9, 2026

Pokémon cards would be global currency during apocalypse, venture capitalist predicts

September 9, 2026

OpenAI says it cracked decades-old math problem — but professor claims they cribbed his work and then threatened him

September 9, 2026

Grocers file antitrust suit to block Mamdami admin’s plan for NYC-owned supermarkets: ‘Predatory pricing’

September 9, 2026

Elon Musk threatens to sue over Alex Gibney’s controversial documentary

September 9, 2026
Facebook X (Twitter) Instagram
The Financial News 247The Financial News 247
Demo
  • Home
  • News
  • Business
  • Finance
  • Companies
  • Investing
  • Markets
  • Lifestyle
  • Tech
  • More
    • Opinion
    • Climate
    • Web Stories
    • Spotlight
    • Press Release
The Financial News 247The Financial News 247
Home » The Risks Of Hegseth’s Testosterone Plan For Soldiers Remain Unknown

The Risks Of Hegseth’s Testosterone Plan For Soldiers Remain Unknown

By News RoomJuly 17, 2026No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn WhatsApp Telegram Reddit Email Tumblr
The Risks Of Hegseth’s Testosterone Plan For Soldiers Remain Unknown
Share
Facebook Twitter LinkedIn Pinterest Email

Secretary of Defense Pete Hegseth has recently announced that active duty male military personnel over age 30 will be screened annually for testosterone levels. As most men’s testosterone levels peak sometime in their 20’s, with a steady but slow decline in the decades that follow, having a so-called testosterone “deficiency” after age 30 can be addressed with testosterone supplementation. While this option will be wholly voluntary, the testing will be incorporated into routine annual physicals of all active military personnel born as male.

Testosterone is a hormone present in both males and females, produced by the male testes and the female ovaries and adrenal glands. In males, it is responsible for testicular growth, sperm production and libido, facial hair, deeper vocal pitch and body hair. It also works to promote bone and muscle strength and density. If testosterone levels are too low, at any age, this can lead to muscle and bone weakness, fatigue, and decline in libido. Testosterone in females is important for ovarian function, libido and bone and muscle health as well.

There are medical conditions in both males and females that occur if testosterone levels are either too high or too low, leading to sexual dysfunction, bone and muscle weakness, and generalized fatigue. In women, high testosterone levels can lead to the condition PMOS, or polyendocrine metabolic ovarian syndrome, previously referred to as PCOS, or polycystic ovary syndrome. This condition, present in up to one in eight premenopausal women, is associated multiple systemic issues, including irregular periods, ovarian cysts and infertility.

While testosterone supplements for males are not new, the Defense Department is now describing the testosterone testing and treatment initiative as a component of the “High T Department of War” as Hegseth described in a video on July 15, 2026. The concept of “High T” is that higher testosterone levels are associated with strength, virility and ability to be better fighters. Testosterone replacement therapy, or TRT, is a popular medication for men with both normal and low testosterone levels, as it has been linked to longevity, better libido, and better musculoskeletal health. Women also use TRT as a component of perimenopausal and menopausal therapy.

But while TRT can be obtained easily, even without a prescription as “off-label” over-the-counter medications, it is otherwise considered to be a controlled substance, requiring a physician to prescribe it. Doctors have a range of views regarding issues of both testosterone level monitoring as well as administration of TRT for low testosterone levels. For men with lower levels but no symptoms, it’s important to provide counseling regarding potential risks and side effects, such as minor nuisances including acne and breast tenderness to more severe risks such as blood clots, fertility changes and mental status changes. There are currently no specific medical guidelines when it comes to routine testosterone level testing in asymptomatic men as young as age 30.

Symptoms of low testosterone in men, including fatigue, erectile dysfunction, lowered libido and bone and muscle issues can be addressed and treated quite successfully with TRT. An FDA expert panel on testosterone replacement therapy for men met in December 2025 to better delineate protocols for monitoring and treating men with low testosterone levels, with or without symptoms. The US Department of Health and Human Services requested revising treatment guidelines as well as updating data regarding cardiovascular and prostate cancer risks of TRT, stating that several studies have recently demonstrated that these risks are actually lower than had been previously reported.

When it comes to young men, especially in their 30’s, when the natural decline of testosterone levels begins, it is unclear what will be offered to them as enlisted military personnel. TRT is a lifelong treatment, for one, and even if some of the risks, particularly cardiovascular disease and prostate cancer, are lower than had been previously thought, part of the treatment must include monitoring for any side effects as well as continuing to measure testosterone levels. Issues of potential fertility decline in this male population also need to be addressed, as well as signs of high testosterone including sleep issues, excess body hair, liver disease, weight gain and mood disorders.

As with consideration of any new medication, understanding implications, both good and bad, short-term and long-term, need to be fully discussed with any patient and treating physician.

Potential Risks Of Hegseth
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related News

Why Your Security Stack Was Never Built For This

September 9, 2026

Work Has A Supply Chain Problem. AI Just Made That Problem Urgent

September 9, 2026

Enterprise AI Doesn’t Need A Bigger Brain; It Needs A Confidence Gate

September 9, 2026

The First Trillion-Dollar Spend Without A Mature Measurement Layer

September 9, 2026

Why Your AI Guardrails Are Only As Real As Your Runtime Visibility

September 9, 2026

Why Payment Speed Alone Won’t Differentiate Your Business

September 9, 2026
Add A Comment
Leave A Reply Cancel Reply

Don't Miss

Pokémon cards would be global currency during apocalypse, venture capitalist predicts

Business September 9, 2026

A high-rolling venture capitalist says Pokémon cards would become the global currency during an apocalypse,…

OpenAI says it cracked decades-old math problem — but professor claims they cribbed his work and then threatened him

September 9, 2026

Grocers file antitrust suit to block Mamdami admin’s plan for NYC-owned supermarkets: ‘Predatory pricing’

September 9, 2026

Elon Musk threatens to sue over Alex Gibney’s controversial documentary

September 9, 2026
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Our Picks

LA’s Lucas Museum sued by contractor over $30-a-year state land deal

September 9, 2026

Ford under fire from GOP, Trump administration over China ties

September 9, 2026

Trump claims oil, gas prices will fall ‘right after’ midterm elections

September 9, 2026

Treasury reveals $6B in debt buybacks, triple the normal level – but markets slump

September 9, 2026
The Financial News 247
Facebook X (Twitter) Instagram Pinterest
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact us
© 2026 The Financial 247. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.